Clinical Trials Update: March 20 2006
Asthma (Pediatric) Circulation Disorders Urinary Incontinence
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This clinical research study will evaluate the effectiveness and safety of an investigational drug in children between ages 6 and 12 who have moderate-to-severe, persistent allergic asthma. Children who have had a diagnosis of allergic asthma for more than one year, have experienced an asthma attack within the past year, are using an asthma inhaler (corticosteroid), and do not have a serious medical or surgical condition may be eligible. The research sites are located throughout the United States.
This gene therapy study will evaluate the safety and efficacy of intramuscular gene transfer using Vascular Endothelial Growth Factor (VEGF) or placebo in patients with moderate to high-risk critical limb ischemia (poor blood circulation in the leg). Volunteers who are at least 21 years old, have critical limb ischemia, have severe blockages in at least one artery in the affected leg as demonstrated by an angiogram, have not had any evidence of malignant neoplasms (other than non-melanoma skin cancer or in situ cervical carcinoma) within the last five years, are not pregnant or lactating, and have not had a history of alcohol or drug abuse within three months of screening may be eligible. The research site is located in Boston, Mass.
This is a research study of an investigational medication for overactive bladder. Women who are over 18 years of age and have a history of overactive bladder for at least six months may qualify. Participants receive study medication and study-related physical exam at no cost Research site located in Philadelphia, Penn.
Copyright 2006 CenterWatch. All rights reserved.